I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Activity and Safety of Mobocertinib (TAK-788) in Previously..:
Riely, Gregory J
;
Neal, Joel W
;
Camidge, D Ross
...
qt8rg5348g. , 2021
Link:
https://escholarship.org/uc/item/8rg5348g
RT Journal T1
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt8rg5348g&Exemplar=1&LAN=DE A1 Riely, Gregory J A1 Neal, Joel W A1 Camidge, D Ross A1 Spira, Alexander I A1 Piotrowska, Zofia A1 Costa, Daniel B A1 Tsao, Anne S A1 Patel, Jyoti D A1 Gadgeel, Shirish M A1 Bazhenova, Lyudmila A1 Zhu, Viola W A1 West, Howard L A1 Mekhail, Tarek A1 Gentzler, Ryan D A1 Nguyen, Danny A1 Vincent, Sylvie A1 Zhang, Steven A1 Lin, Jianchang A1 Bunn, Veronica A1 Jin, Shu A1 Li, Shuanglian A1 Jänne, Pasi A PB eScholarship, University of California YR 2021 K1 Biomedical and Clinical Sciences K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Clinical Trials and Supportive Activities K1 Lung Cancer K1 Cancer K1 Lung K1 Clinical Research K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Adult K1 Aged K1 80 and over K1 Aniline Compounds K1 Antineoplastic Agents K1 Carcinoma K1 Non-Small-Cell Lung K1 ErbB Receptors K1 Exons K1 Female K1 Humans K1 Indoles K1 Lung Neoplasms K1 Male K1 Maximum Tolerated Dose K1 Middle Aged K1 Mutagenesis K1 Insertional K1 Progression-Free Survival K1 Pyrimidines K1 Treatment Outcome K1 Biochemistry and cell biology JF qt8rg5348g LK http://dx.doi.org/https://escholarship.org/uc/item/8rg5348g DO https://escholarship.org/uc/item/8rg5348g SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)